Diabetes MedsCheck study
June 17, 2013
FOURTEEN NSW community
pharmacies are taking part in a new
research initiative which aims to
evaluate the effectiveness of the
govt’s Diabetes MedsCheck service.
Conducted by Roche Diabetes
Care and the University of
Technology Sydney, the study
is being led by UTS Professor
of Pharmacy Practice, Charlie
Benrimoj, with a further 15
pharmacies also expected to enrol
in the six month program.
The study will investigate the
impact of Diabetes MedsCheck on
health outcomes, incorporating the
suite of professional services tools
from Roche Diagnostics.
These include Meter Match,
DVDs and YouTube tutorials on
blood glucose meter and lancing
techniques, the Accu-Check 360°
View 3-day Profiling Tool, and
instructions on how to follow a
structured self-monitoring of blood
glucose regimen.
“Since the Diabetes MedsCheck
service was introduced under
the Fifth Community Pharmacy
Agreement in July 2012, no
research has been undertaken
to assess the level of impact the
service has had on the person
with diabetes or on community
pharmacy - until now.” Benrimoj said.
He said the expansion of
professional services “is an
excellent strategy to maintain
the viability and sustainability of
community pharmacy”.
And Roche manager, Scientific
and Regulatory Affairs, George
Koumantakis, said that partnering
with the UTS pharmacy department
as an “ongoing education hub” is
important to ensure the Accu-
Check Pharmacy Sales team
remains informed about changes
impacting community pharmacy.
“It is our strong believe that
maximising the Roche tools and
servies already available will help
pharmacists enhance their role in
providing diabetes education and
health services to the community”.
The above article was sent to subscribers in Pharmacy Daily's issue from 17 Jun 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Jun 13
